Advertisement

Topics

Generic Drugs: First-Cycle Review Times Improve, But Hundreds Of ANDAs Still Pending

05:03 EDT 4 Jul 2017 | SCRIP

US FDA cut first-cycle review time 46% between fiscal year 2013 and FY 2015, but more than 900 ANDAs still...

      

Related Stories

 

Original Article: Generic Drugs: First-Cycle Review Times Improve, But Hundreds Of ANDAs Still Pending

NEXT ARTICLE

More From BioPortfolio on "Generic Drugs: First-Cycle Review Times Improve, But Hundreds Of ANDAs Still Pending"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...